Sarah St. John, PhD, joins business development team
Catalyst Clinical Research is thrilled to welcome Sarah St. John, PhD, to Catalyst as our new Vice President of Business Development. Sarah has over 15 years of experience in the life sciences industry across R&D, CROs, Patient Support Services, and Clinical Site Networks, where she has built and led multifaceted teams across sales, marketing, patient recruitment marketing, and commercial operations, including budgets and proposals. Sarah earned her doctorate in organic chemistry from Purdue University and completed a postdoctoral fellowship in protein biochemistry and X-ray crystallography, brining a unique blend of scientific expertise and commercial leadership to Catalyst Clinical Research.
Before joining Catalyst, Sarah was the Chief Commercial Officer of Elite Clinical Network. Prior to that, she served in key leadership roles at Phenomenex, Covance, and Occam Heath Services. Sarah’s success is driven by her ability to harness data, foster collaboration, and prioritize integrity in decision making. She brings a passion for advancing scientific innovation and improving patient outcomes to Catalyst.
Read more about Sarah and other Catalyzers.
